IGI Logo

Key News

Colgate-Palmolive India Q4 net profit jumps 54% to Rs 314.6 crore

Consumer goods major Colgate-Palmolive India on Monday reported a 54.1 per cent increase in its net profit to Rs 314.6 crore in Q4 versus a year ago, helped by a low base and all-round growth across categories. Its net sales were up 20.2 per cent YoY to Rs 1,275.01 crore in Q4, versus Rs 1,062.35 crore in the year-ago period. Ram Raghavan, managing director at ColgatePalmolive (India), said the company continued to witness strong momentum across segments. “Our focused approach to executing our strategic initiatives has been instrumental in our continued abilities to sustain our growth momentum versus year ago as well as on a sequential basis,” he said.

Bharti Airtel reports consolidated net profit of Rs 759 crore in Q4

Bharti Airtel on Monday reported a consolidated net profit of Rs 759 crore in the fourth quarter of 2020-21, after provisioning for the adjusted gross revenue (AGR) payment due to the central government. The telecom operator had posted a loss of Rs 5,237 crore in the corresponding period of 2019-20. In the third quarter of FY21, the company had posted a consolidated net profit of Rs 854 crore, helped by an one-time gain from the merger of Indus Towers.

Orient Cement Q4 net profit rises over two-folds to Rs 99.87 crore

C K Birla group firm Orient Cement Ltd on Monday reported an over twofold jump in net profit at Rs 99.87 crore in the fourth quarter ended March 2021. It had posted a net profit of Rs 44.06 crore in the January-March quarter a year ago, Orient Cement said in a BSE filing. Its revenue from operation rose 27.06 per cent to Rs 831.61 crore during the quarter under review as against Rs 654.52 crore in the corresponding period a year earlier. Total expenses were at Rs 680.83 crore in Q4/FY2020-21, up 14.96 per cent as against Rs 654.52 crore.

Gland Pharma's Q4 consolidated net profit up 34% at Rs 260.4 crore

Drug firm Gland Pharma on Monday reported a 34 per cent rise in its consolidated net profit to Rs 260.4 crore for the fourth quarter ended March 2021, on account of robust sales. The company had posted a net profit of Rs 194.8 crore for the corresponding period of the previous fiscal, Gland Pharma said in a BSE filing. Consolidated revenue from operations of the company stood at Rs 887.7 crore for the quarter under consideration. It was Rs 635.2 crore in the year-ago period, it added.

Federal Bank posts best ever quarterly net profit, up 59% at Rs 477 cr

Kochi-headquartered private sector lender Federal Bank has reported a 59 per cent year-on-year (YoY) growth in net profit in the March quarter of FY21 due to lower provisions and a steady net interest income (NII). The banks’ net profit for the period was Rs 477.81 crore, its highest ever in a quarter, compared to Rs 301.23 crore a year ago.

Tata Motors Jamshedpur plant to undergo block closure from May 18-22

Homegrown automobile giant Tata Motors will undertake a block closure at its Jamshedpur facility from May 18 to May 22, as per an internal communication sent to its employees on Monday. The employees have been asked to report for duty on May 24. The announcement comes ahead of the company's board meeting scheduled on May 18 to consider and approve the audited financial results for the quarter and financial year ended March 31. A Tata Motors spokesperson confirmed the block closure saying that it is a routine closure for "maintenance".

To Read Complete Report & Disclaimer Click Here

Above views are of the author and not of the website kindly read disclaimer